• 00D
  • 00H
  • 00M
  • 00S

Brisbane Convention & Exhibition Centre

Dr Jordana McLoone

School of Clinical Medicine, UNSW Medicine & Health, Discipline of Paediatrics, UNSW Sydney, Australia
Jordana McLoone

Dr McLoone is an expert in developing and evaluating models of childhood cancer survivorship care, which recognises the late morbidity and mortality associated with a diagnosis of childhood cancer and its intense treatment.

McLoone led the largest study of childhood cancer survivors in the Southern Hemisphere, which evaluated survivors’ long-term physical and mental health, barriers to accessing care, and survivorship service delivery across Australia and New Zealand (the ANZCHOG Survivorship Study). They also led the development of an innovative telehealth intervention to provide effective, accessible, and sustainable care and education to survivors from child to adulthood, which is now being implemented in usual clinical care.

A strong commitment to consumer-led intervention design is evidenced by McLoone’s investment in extensive co-design work with young people, parents, paediatric and adult healthcare professionals to ensure a consumer-finalised intervention. McLoone holds leadership roles within peak national and international bodies, including ANZCHOG, COSA and SIOP.

Key dates

Abstract submissions open:
Monday 28 October 2024

Early bird registration launch:
Monday 9 December 2024

Abstract submissions close:
Friday 31 January 2025

Early bird registration ends: 
Monday 24 February 2025

Standard registrations:
Monday 24 February 2025

Abstract notification: 
February 2025

The Australian Children’s Brain Cancer Conference:
19-21 March 2025